COMMUNIQUÉS West-GlobeNewswire

The Joint Corp. Reports Second Quarter 2019 Financial Results
08/08/2019
- Increases System-Wide Gross Sales 34%, Compared to Q2 2018 - - Sells 45 Franchise Licenses, Up from 18 in Q2 2018 – - Opens 15 Clinics, 14 Franchised and 1 Greenfield, Compared to 8 Franchised Clinics in Q2 2018 - [...]
Cambium Networks Reports Second Quarter 2019 Financial Results
08/08/2019
Record revenues of $69.2 million, up 13% year-over-year Wi-Fi revenues increased 24% year-over-year, up 51% sequentially Gross margin of 49.6%, non-GAAP gross margin of 50.1% Cash provided by operating activities of $6. [...]
Calithera Biosciences Reports Second Quarter 2019 Financial Results and Recent Highlights
08/08/2019
--Calithera to Provide Corporate Update via Conference Call and Webcast at 2:00 p.m. PT on August 8, 2019-- SOUTH SAN FRANCISCO, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a [...]
Opiant Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update
08/08/2019
SANTA MONICA, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today reported [...]
Caladrius Biosciences Reports 2019 Second Quarter and First Six Months Financial Results and Provides Corporate Update
08/08/2019
Confirmatory Phase 3 Study Protocol Finalized for CLBS14 in No-Option Refractory Disabling Angina Conference call begins today at 4:30 p.m. Eastern time BASKING RIDGE, N.J., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Caladrius [...]
Avadel Pharmaceuticals Receives New PDUFA Date for AV001 of December 15, 2019
08/08/2019
PDUFA Action Extended 3 Months; Launch Remains on Track for 1Q 2020 DUBLIN, Ireland, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218 for narcolepsy, [...]
Sensus Healthcare Reports Second Quarter 2019 Financial Results
08/08/2019
· Resumes double-digit revenue growth, up 23% over the prior year quarter · Affirms expectations for full-year double-digit revenue growth · Conference call begins at 4:30 p.m. East ern time today BOCA RATON, Fla., Aug [...]
Helius Medical Technologies, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update; Reaffirms Full Year 2019 Outlook
08/08/2019
NEWTOWN, Pa., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial [...]
Osmotica Pharmaceuticals plc Reports Second Quarter 2019 Results
08/08/2019
Second quarter 2019 total revenue of $57.5 million On track to submit NDA for RVL-1201 (oxymetazoline hydrochloride ophthalmic solution, 0.1%) for acquired blepharoptosis, or droopy eyelid, by end of Q3 2019 BRIDGEWATER [...]
Rockwell Medical, Inc. Reports Second Quarter 2019 Financial Results
08/08/2019
– Company Records First Commercial Sales of Dialysate Triferic®; FDA Accepts New Drug Application for I.V. Triferic with PDUFA date of March 28, 2020 – WIXOM, Mich., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, [...]
Marrone Bio announces transformative acquisition of Pro Farm Technologies in the $4.6 billion seed- and soil-treatment market
08/08/2019
Pro Farm products expected to substantially accelerate growth trajectory DAVIS, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc . (NASDAQ: MBII), an international leader in sustainable [...]
Marrone Bio announces financing facility to fund future operations and strategic acquisitions
08/08/2019
DAVIS, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc . (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, announced today that it has established a $ [...]
FibroGen Reports Second Quarter 2019 Financial Results
08/08/2019
— On Track to Submit U.S. NDA for Roxadustat in October — — Initiated ZEPHYRUS Phase 3 Study of Pamrevlumab in IPF — Conference Call Today at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time SAN FRANCISCO, Aug. 08, 2019 ( [...]
Tabula Rasa HealthCare Announces Second Quarter 2019 Operating Results
08/08/2019
Second Quarter 2019 Revenue of $76.3 million, growth of 57%; 2019 Guidance Increased MOORESTOWN, N.J., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology [...]
Adamas Reports Second Quarter 2019 Financial Results
08/08/2019
- Second quarter GOCOVRI® product sales of $12.7 million; total prescriptions grew to approximately 6,160 - INROADS Phase 3 study of ADS-5102 (GOCOVRI) for walking impairment in patients with multiple sclerosis (MS) [...]
Principia Biopharma Reports Second Quarter Financial Results
08/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
TearLab Corporation Reports Second Quarter and First Half 2019 Financial Results
08/08/2019
ESCONDIDO, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the second quarter ended June 30, 2019. All [...]
Oncternal Reports Second Quarter 2019 Financial Results and Provides Business Update
08/08/2019
SAN DIEGO, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Interim objective response rate of 100% in evaluable patients with CLL receiving the recommended dosing regimen of cirmtuzumab + ibrutinib supports opening Phase 2 Two [...]
MacroGenics to Participate in Upcoming Investor Conferences
08/08/2019
Rockville, MD, Aug. 08, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

Pages